Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
Key Information
Due Date: June 22, 2026
Agency: United States Department of Health and Human Services
Source: Federal
Funding Categories:
Funding Amount: Not Specified
Funding Type: Cooperative Agreement
Match Required: No
Status: Posted
Contact Info:
grantsinfo@nih.gov
NIH Grants Information grantsinfo@nih.gov
NIH Grants Information grantsinfo@nih.gov
Overview
The purpose of this Program Announcement (PAR) is to enable clinical validation of strong candidate biomarkers for neurological diseases and conditions. Specifically, the goal of this PAR is to enable the rigorous validation of biomarker measurements within the clinical population of interest to establish the positive and negative predictive values of the candidate biomarker consistent with FDA guidelines. This PAR assumes that 1) a candidate biomarker has already been identified, 2) detection method technology has already been developed and analytically validated, and 3) the research and/or clinical need and potential context of use has been identified.
Show More
Key Dates
Posted Date: October 2, 2024
Application Due Date: June 22, 2026
Estimated Award Date: Not Specified
Additional Details
Eligible Applicants
- Public and State controlled institutions of higher education
- Independent school districts
- Native American tribal governments (Federally recognized)
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Public housing authorities/Indian housing authorities
- For profit organizations other than small businesses
- Private institutions of higher education
- County governments
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- City or township governments
- Native American tribal organizations (other than Federally recognized tribal governments)
- Small businesses
- Special district governments
- Others
- State governments